Part 2: Toolboxes to commercialize your molecular assay: Taq Polymerases and Reverse Transcriptases

When developing your own master mix, choosing between different options for Hot Start Taq Polymerases and Reverse Transcriptases can be daunting. From endpoint PCR to multiplex PCR, you can accelerate your assay development process and save time by minimizing trial and error using trusted and proven products from QIAGEN.

In this webinar, let’s break down the key features and differentiators you should look out for when evaluating which DNA Taq Polymerases and Reverse Transcriptases are best suited for your molecular assay.

Got other plans? You can still register and we’ll send you a link to the recorded webinar.

About the speaker

Anna Sobczak, Global Product Manager, Strategic Marketing, OEM

QIAGEN

Anna is currently a Global Product Manager at QIAGEN. She holds a Master of Science in Molecular Biotechnology from the Gdansk University of Technology. She has worked for over five years in sales, product development and marketing of enzymes, joining QIAGEN in 2022, during an acquisition, to oversee the enzymes portfolio. She is an expert in marketing, market research, sales, and project management in new product development.

Jaume Vela Albesa, Global Product Manager, OEM Life Science & Diagnostics

QIAGEN

Jaume Vela holds Master of Science degree in Biomedicine from the Universitat de Barcelona. Jaume was a biomedical science researcher for two years before joining QIAGEN in 2018 and has held the role of global product manager for the OEM and enzymes business for the past two years. Jaume is an expert in molecular biology, biotechnology, marketing, sales, and project management in life science product development.